Finecare cTnI Rapid Quantitative Test - Pack of 25 Tests (W203)

Description: Introducing the Finecare cTnI Rapid Quantitative Test, an advanced diagnostic tool designed for the quantitative measurement of cardiac Troponin I (cTnI). This test offers healthcare professionals a rapid and precise assessment of cardiac biomarker levels, aiding in the diagnosis and management of acute myocardial infarction (AMI) and other cardiac conditions.

Key Features:

1. Quantitative Analysis: The Finecare cTnI Rapid Quantitative Test provides quantitative measurements of cardiac Troponin I levels, allowing for precise assessment of myocardial damage.
2. Rapid Results: With results available within minutes, this test enables prompt clinical decision-making and timely patient management.
3. High Sensitivity and Specificity: Engineered with high sensitivity and specificity, the test ensures accurate and reliable measurement of cTnI levels, supporting precise diagnosis and treatment.
4. User-Friendly Design: Designed for ease of use, the test offers clear and intuitive instructions, making it suitable for healthcare professionals with varying levels of expertise.
5. Convenient Pack Size: Each pack contains 25 tests (W203), providing healthcare facilities with a convenient and cost-effective solution for cTnI assessment.

Benefits:

1. Early Diagnosis of AMI: The Finecare cTnI Rapid Quantitative Test aids in the early diagnosis of acute myocardial infarction (AMI) by providing a rapid and accurate assessment of cardiac Troponin I levels.
2. Timely Intervention: Rapid quantitative measurement enables timely intervention and initiation of appropriate treatment strategies, leading to improved patient outcomes and reduced morbidity and mortality.
3. Risk Stratification: Precise measurement of cTnI levels allows for effective risk stratification and prognosis assessment in patients with suspected cardiac conditions, facilitating personalized patient management.
4. Enhanced Workflow: The rapid test format streamlines diagnostic procedures, reducing waiting times for results and optimizing resource utilization in emergency departments and cardiac care units.
5. Cost-Effectiveness: Offering accurate results at a reasonable cost, the Finecare cTnI Rapid Quantitative Test ensures cost-effective assessment of cardiac biomarkers without compromising quality.